Article Information
History
- June 10, 2021.
Article Versions
- Version 1 (March 8, 2021 - 05:06).
- You are currently viewing Version 2 of this article (June 10, 2021 - 09:24).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lloyd A. C. Chapman, PhD1,*,
- Poojan Shukla1,2,
- Isabel Rodríguez-Barraquer, MD PhD1,3,
- Priya B. Shete, MD, MPH4,5,
- Tomás M. León, MSc PhD4,
- Kirsten Bibbins-Domingo, MD PhD1,6,
- George W. Rutherford, MD6,7,
- Robert Schechter, MD8 and
- Nathan C. Lo, MD PhD1,*
- 1Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- 2Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA
- 3Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA
- 4Coronavirus Sciences Branch, California Department of Public Health, Richmond, CA, USA
- 5Division of Pulmonary and Critical Care Medicine and Center for Tuberculosis, University of California San Francisco, CA, USA
- 6Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
- 7Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
- 8Immunization Branch, California Department of Public Health, Richmond, CA, USA
- ↵*Correspondence
: Lloyd A. C. Chapman, PhD and Nathan C. Lo, MD PhD, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA 94110, lloyd.chapman1{at}lshtm.ac.uk, nathan.lo{at}ucsf.edu
Posted June 10, 2021.
